Welcome to our dedicated page for Arbe Robotics SEC filings (Ticker: ARBEW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Arbe Robotics Ltd. (ARBEW) SEC filings provide insight into the company’s activities as a foreign private issuer focused on 4D Imaging Radar and advanced radar chips for Advanced Driver Assistance Systems (ADAS) and autonomous driving. Through filings under the Securities Exchange Act of 1934, investors can review how the company describes its radar technology focus, geographic segments, and corporate structure.
Form 20-F and related filings outline Arbe Robotics Ltd.’s status as a foreign issuer and its business as a research and development company in the field of chips for advanced radar systems. These documents describe that its radar systems are mainly intended for ADAS adapted for autonomous vehicles, with additional non-automotive uses, and list geographic segments such as Sweden, China, Germany, Hong Kong, the United States, Israel, Switzerland, Italy, and others.
Form 6-K current reports furnish information on specific events. One Form 6-K details a 2025 annual general meeting at which shareholders elected Class I directors, approved an increase in registered (authorized) share capital by adding ordinary shares, and amended the Articles of Incorporation to reflect this change. The same report notes that a press release announcing a director’s election was furnished as an exhibit and that the Form 6-K, excluding the press release content, is incorporated by reference into registration statements on Form F-3 or Form S-8.
On this filings page, users can access such SEC documents and use AI-powered summaries to interpret their contents. The platform highlights key points from annual and current reports, helping readers understand how Arbe Robotics Ltd. presents its radar-focused business, corporate actions, and regulatory disclosures.
Arbe Robotics reported very small revenue and continued heavy losses while outlining a strategic shift and leadership change. Revenue reached
Net loss improved to
Arbe ended 2025 with
Separately, Arbe appointed Ram Machness, its longtime Chief Business Officer, as Chief Executive Officer effective
Arbe Robotics Ltd. received an updated ownership filing showing that venture fund Canaan Partners Israel and related entities, along with Ehud M. Levy, report significant holdings in the company’s ordinary shares.
Canaan Partners Israel (CPI) (Cayman) L.P. directly owns 7,840,262 ordinary shares, representing about 7.2% of the class. Its general partners, Canaan Partners Israel (CPI) GP, L.P. and Canaan Partners Israel (A.G.P) 1 Ltd, may each be deemed to beneficially own the same 7,840,262 shares.
Ehud M. Levy, as the control person of these entities, may be deemed to beneficially own 7,893,595 ordinary shares, or roughly 7.3% of the company. This includes 53,333 shares underlying stock options exercisable within 60 days of December 31, 2025. All ownership percentages are based on 108,859,502 ordinary shares outstanding as of September 30, 2025.
Arbe Robotics Ltd. is scheduling a live conference call on February 26, 2026 at 8:30 a.m. Eastern Time to discuss its fourth quarter 2025 and full year 2025 financial results, which will be released earlier that day before the U.S. market opens.
The call will feature CEO Kobi Marenko and CFO Karine Pinto-Flomenboim, and will be accessible via webcast on Arbe’s investor relations website or by toll-free phone numbers in the U.S., Israel and internationally. A replay webcast will be available the following day.
Arbe describes itself as a global leader in ultra-high-resolution automotive radar chipsets supporting advanced driver-assistance and autonomous driving systems, and reiterates standard forward-looking statement warnings referencing geopolitical, macroeconomic and currency risks noted in its prior annual report.
Arbe Robotics Ltd. is conducting a primary offering of 11,500,000 ordinary shares at $1.40 per share under its shelf registration. The underwriters have a 30‑day option to buy up to 1,725,000 additional shares, which would increase the deal size if fully exercised.
The company expects gross proceeds of $16.1 million and approximately $15.1 million in proceeds before expenses, or $17.4 million if the option is fully exercised. After underwriting fees and estimated expenses, net proceeds are estimated at about $14.8 million, or $17.1 million with full option exercise.
Arbe plans to use the cash for working capital and general corporate purposes108,859,502 as of September 30, 2025 and are expected to be 120,359,502 after the offering, or 122,084,502 if the option is fully exercised, meaning existing holders are diluted but the company gains additional funding to support its 4D imaging radar business.
Arbe Robotics Ltd. (ARBEW) submitted a Form 144 disclosing a proposed sale of 162,158 ordinary shares with an aggregate market value of $315,170, scheduled approximately for 09/22/2025 on NASDAQ. The securities were originally acquired in a private placement on 03/30/2016 from Arbe Robotics Ltd., totaling 4,261,734 shares at cash payment. The filing also reports recent sales by Canaan Partners Israel of 100,000 and 87,842 ordinary shares on 09/18/2025 and 09/19/2025 respectively, generating gross proceeds of $149,690.00 and $147,864.44. The filing includes the required representation that the seller is not aware of undisclosed material adverse information.
Form 144 notice for ARBEW shows an intended sale of 87,842 ordinary shares on or about 09/19/2025 through Raymond James & Associates on NASDAQ, with an aggregate market value of $147,574.56. The filing reports that these shares were originally acquired in a private placement on 03/30/2016 from Arbe Robotics Inc for cash, and that the filer previously sold 100,000 ordinary shares on 09/18/2025 (gross proceeds $147,684.05) by Canaan Partners Israel. The issuer outstanding share count is listed as 105,163,188. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
Form 144 notice: A holder intends to sell 100,000 ordinary shares of Arbe Robotics Ltd. (ticker ARBEW) through Raymond James & Associates on 09/18/2025 on the NASDAQ. The aggregate market value of the proposed sale is reported as $149,690.00 and the issuer has 105,163,188 shares outstanding. The shares were originally acquired on 03/30/2016 in a private placement from Arbe Robotics Ltd., with 4,261,734 shares listed as acquired on that date, and payment was in cash. No securities sold in the past three months are reported.
Arbe Robotics Ltd. reported the results of its 2025 annual general meeting. Shareholders elected Dr. Noam Arkind and Mr. Chris Van Dan Elzen as Class I directors, adding Van Dan Elzen to the company’s board.
Investors also approved an increase in Arbe’s registered share capital by NIS 7,560, representing 35,000,000 additional ordinary shares, bringing the total authorized ordinary shares to 200,000,000 and amending the Articles of Incorporation accordingly. All proposals described in the previously furnished proxy statement were approved by the required majorities.
The company noted that a press release announcing Van Dan Elzen’s election was issued on September 18, 2025 and furnished as an exhibit, and reiterated standard cautions about forward-looking statements, including risks related to marketing its chipset technology, global trade policies, and geopolitical and economic conditions affecting Israel.